Novel alpha-MSH peptide analogs for melanoma targeting

Lois J. Loescher, Monika Janda, H. Peter Soyer, Kimberly Shea, Clara Curiel-Lewandrowski, Advances in Skin Cancer Early Detection and Diagnosis Seminars in Oncology Nursing. ,vol. 29, pp. 170- 181 ,(2013) , 10.1016/J.SONCN.2013.06.003

ZALFA ABDEL-MALEK, ITARU SUZUKI, AKIHIRO TADA, SUNGBIN IM, CAN AKCALI, The melanocortin-1 receptor and human pigmentation Annals of the New York Academy of Sciences. ,vol. 885, pp. 117- 133 ,(2006) , 10.1111/J.1749-6632.1999.TB08669.X

ANA LUISA KADEKARO, HIROMI KANTO, RENNY KAVANAGH, ZALFA A. ABDEL-MALEK, Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival. Annals of the New York Academy of Sciences. ,vol. 994, pp. 359- 365 ,(2003) , 10.1111/J.1749-6632.2003.TB03200.X

Dongsi Lu, Dag Inge Vage, Roger D. Cone, A Ligand-Mimetic Model for Constitutive Activation of the Melanocortin-1 Receptor Molecular Endocrinology. ,vol. 12, pp. 592- 604 ,(1998) , 10.1210/MEND.12.4.0091

Sanjiv S Agarwala, Current systemic therapy for metastatic melanoma. Expert Review of Anticancer Therapy. ,vol. 9, pp. 587- 595 ,(2009) , 10.1586/ERA.09.25

Helen Davies, Graham R. Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J. Garnett, William Bottomley, Neil Davis, Ed Dicks, Rebecca Ewing, Yvonne Floyd, Kristian Gray, Sarah Hall, Rachel Hawes, Jaime Hughes, Vivian Kosmidou, Andrew Menzies, Catherine Mould, Adrian Parker, Claire Stevens, Stephen Watt, Steven Hooper, Rebecca Wilson, Hiran Jayatilake, Barry A. Gusterson, Colin Cooper, Janet Shipley, Darren Hargrave, Katherine Pritchard-Jones, Norman Maitland, Georgia Chenevix-Trench, Gregory J. Riggins, Darell D. Bigner, Giuseppe Palmieri, Antonio Cossu, Adrienne Flanagan, Andrew Nicholson, Judy W. C. Ho, Suet Y. Leung, Siu T. Yuen, Barbara L. Weber, Hilliard F. Seigler, Timothy L. Darrow, Hugh Paterson, Richard Marais, Christopher J. Marshall, Richard Wooster, Michael R. Stratton, P. Andrew Futreal, Mutations of the BRAF gene in human cancer Nature. ,vol. 417, pp. 949- 954 ,(2002) , 10.1038/NATURE00766

Rebecca Siegal, KD Miller, Ahmddin Jemal, Cancer statistics, 2012 CA: A Cancer Journal for Clinicians. ,vol. 62, pp. 10- 29 ,(2012) , 10.3322/CAAC.20138

Silvia S. Jurisson, Yubin Miao, Nellie K. Owen, Zhen Cheng, Thomas P. Quinn, JianQing Chen, Timothy J. Hoffman, Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties. The Journal of Nuclear Medicine. ,vol. 42, pp. 1847- 1855 ,(2001)

A Y Bedikian, G R Weiss, S S Legha, H A Burris, J R Eckardt, J Jenkins, O Eton, A C Buzaid, L Smetzer, D D Von Hoff, Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy. Journal of Clinical Oncology. ,vol. 13, pp. 2895- 2899 ,(1995) , 10.1200/JCO.1995.13.12.2895

Reingard Senekowitsch-Schmidtke, Beate Diefenbach, Horst Kessler, Ute Reuning, Roland Haubner, Hans-Jürgen Wester, Markus Schwaiger, Gerhard Stöcklin, Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting The Journal of Nuclear Medicine. ,vol. 40, pp. 1061- 1071 ,(1999)